TY - JOUR
T1 - Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
AU - Burgel, Pierre Régis
AU - Southern, Kevin W.
AU - Addy, Charlotte
AU - Battezzati, Alberto
AU - Berry, Claire
AU - Bouchara, Jean Philippe
AU - Brokaar, Edwin
AU - Brown, Whitney
AU - Azevedo, Pilar
AU - Durieu, Isabelle
AU - Ekkelenkamp, Miquel
AU - Finlayson, Felicity
AU - Forton, Julian
AU - Gardecki, Johanna
AU - Hodkova, Pavla
AU - Hong, Gina
AU - Lowdon, Jacqueline
AU - Madge, Su
AU - Martin, Clémence
AU - McKone, Edward
AU - Munck, Anne
AU - Ooi, Chee Y.
AU - Perrem, Lucy
AU - Piper, Amanda
AU - Prayle, Andrew
AU - Ratjen, Felix
AU - Rosenfeld, Margaret
AU - Sanders, Don B.
AU - Schwarz, Carsten
AU - Taccetti, Giovanni
AU - Wainwright, Claire
AU - West, Natalie E.
AU - Wilschanski, Michael
AU - Bevan, Amanda
AU - Castellani, Carlo
AU - Drevinek, Pavel
AU - Gartner, Silvia
AU - Gramegna, Andrea
AU - Lammertyn, Elise
AU - Landau, Eddie (Edwina) C.
AU - Plant, Barry J.
AU - Smyth, Alan R.
AU - van Koningsbruggen-Rietschel, Silke
AU - Middleton, Peter G.
N1 - Publisher Copyright:
© 2024
PY - 2024/3
Y1 - 2024/3
N2 - This is the third in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on recognising and addressing CF health issues. The guidance was produced with wide stakeholder engagement, including people from the CF community, using an evidence-based framework. Authors contributed sections, and summary statements which were reviewed by a Delphi consultation. Monitoring and treating airway infection, inflammation and pulmonary exacerbations remains important, despite the widespread availability of CFTR modulators and their accompanying health improvements. Extrapulmonary CF-specific health issues persist, such as diabetes, liver disease, bone disease, stones and other renal issues, and intestinal obstruction. These health issues require multidisciplinary care with input from the relevant specialists. Cancer is more common in people with CF compared to the general population, and requires regular screening. The CF life journey requires mental and emotional adaptation to psychosocial and physical challenges, with support from the CF team and the CF psychologist. This is particularly important when life gets challenging, with disease progression requiring increased treatments, breathing support and potentially transplantation. Planning for end of life remains a necessary aspect of care and should be discussed openly, honestly, with sensitivity and compassion for the person with CF and their family. CF teams should proactively recognise and address CF-specific health issues, and support mental and emotional wellbeing while accompanying people with CF and their families on their life journey.
AB - This is the third in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on recognising and addressing CF health issues. The guidance was produced with wide stakeholder engagement, including people from the CF community, using an evidence-based framework. Authors contributed sections, and summary statements which were reviewed by a Delphi consultation. Monitoring and treating airway infection, inflammation and pulmonary exacerbations remains important, despite the widespread availability of CFTR modulators and their accompanying health improvements. Extrapulmonary CF-specific health issues persist, such as diabetes, liver disease, bone disease, stones and other renal issues, and intestinal obstruction. These health issues require multidisciplinary care with input from the relevant specialists. Cancer is more common in people with CF compared to the general population, and requires regular screening. The CF life journey requires mental and emotional adaptation to psychosocial and physical challenges, with support from the CF team and the CF psychologist. This is particularly important when life gets challenging, with disease progression requiring increased treatments, breathing support and potentially transplantation. Planning for end of life remains a necessary aspect of care and should be discussed openly, honestly, with sensitivity and compassion for the person with CF and their family. CF teams should proactively recognise and address CF-specific health issues, and support mental and emotional wellbeing while accompanying people with CF and their families on their life journey.
KW - Breathing
KW - CFRD
KW - Complications
KW - Cystic fibrosis
KW - End of life
KW - Liver
KW - Lung infection
KW - Mental health
KW - Pulmonary
KW - Transplant
UR - https://www.scopus.com/pages/publications/85185246234
U2 - 10.1016/j.jcf.2024.01.005
DO - 10.1016/j.jcf.2024.01.005
M3 - Article
C2 - 38233247
AN - SCOPUS:85185246234
SN - 1569-1993
VL - 23
SP - 187
EP - 202
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 2
ER -